US2021113530A1PendingUtilityA1

Liquid formulations of bendamustine

74
Assignee: CEPHALON INCPriority: Sep 25, 2008Filed: Sep 9, 2020Published: Apr 22, 2021
Est. expirySep 25, 2028(~2.2 yrs left)· nominal 20-yr term from priority
Inventors:Anthony S. DragerRachel Y. LabellPiyush R. Patel
A61K 31/4184A61K 47/22A61K 47/20A61K 9/08A61K 47/40A61K 9/0019A61K 47/10A61K 47/18A61P 35/02A61P 35/00
74
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Stable liquid formulations of bendamustine, and pharmaceutically acceptable salts thereof, and polar aprotic solvents, are described.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A liquid formulation comprising bendamustine and 1-methyl-2-pyrrolidone (NMP).

Join the waitlist — get patent alerts

Track US2021113530A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.